Nombre del producto:Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH

IUPAC Name:(2S)-6-[2-(2-{2-[2-(2-{2-[(4S)-5-(tert-butoxy)-4-[18-(tert-butoxy)-18-oxooctadecanamido]-5-oxopentanamido]ethoxy}ethoxy)acetamido]ethoxy}ethoxy)acetamido]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid

CAS:1662688-20-1
Fórmula molecular:C64H101N5O16
Pureza:97%
Número de catálogo:CM553755
Peso molecular:1196.53

Unidad de embalaje Stock disponible Precio($) Cantidad
CM553755-25g in stock ƛƥƛŵ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1662688-20-1
Fórmula molecular:C64H101N5O16
Punto de fusión:-
Código de sonrisas:CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C
Densidad:
Número de catálogo:CM553755
Peso molecular:1196.53
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Fatty Acid Modified Side Chains
Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.